INOVIS Intelligent Competitor Strategies  CONTACT US



Specialized primary competitive intelligence and strategic analysis & planning for the life sciences industry

INOVIS: Specialized Primary Intelligence and Strategic Consulting for Life Sciences / Biotech / Pharmaceuticals and Digital Health

Pharmaceuticals, biotechnology, medical devices, diagnostics, genomics, CROs and managed care companies have relied on our primary intelligence and strategic analysis services since 1992

Our Competitive Intelligence service expertise includes Branded, Gx, Biosimilar, telehealth/m-health/e-health (learn more about our Digital Health CI proficiencies+).

Baljit Singh PhD, INOVIS Managing Director and Partner, Life Sciences Group
VIEW 2m VIDEOlearn more


Baljit shares how INOVIS supports decision-making and ultimately enables us to be a thought partner

in-depth coverage

— clinical— regulatory
— commercial— manufacturing
— development— diagnostics
— market access. . . and more

Regulatory Intelligence

core specialty areas

Over the past 30 years we have conducted research across most core specialty areas, including:

  • Cardiology
  • Oncology
  • Neurology/CNS
  • Autoimmune Diseases
  • Vaccines
  • Generics
  • Biosimilars
  • Rx-to-OTC
  • Pain Management
  • Diabetes/Metabolism
  • Respiratory
  • Infectious Diseases
  • Urology
  • Endocrinology

Our Strategic Consulting practice uses innovative and best-in-class research techniques to help leverage the core strengths of the client's organization, to create a long-term competitive edge in the marketplace

Life Sciences Competitive Intelligence and Strategic Consulting

Harshal Kubavat PhD, INOVIS Head of Strategic Consulting, Global Pharmaceuticals and Life Sciences Group
VIEW 2m VIDEOlearn more

UNCERTAINTY learn more

Harshal Kubavat, INOVIS' Head of Strategic Consulting, Global Pharmaceuticals & Life Sciences Group, explores how INOVIS helps navigate uncertainty through competitively driven strategy.

thank you for your interest in INOVIS Competitor Intelligence and Strategy